Telecommunications

Airtel Nigeria and AXA Mansard Launch Digital Health Insurance Scheme

Published

on

Airtel Nigeria and AXA Mansard have recently joined forces to launch a digital health insurance scheme that will provide basic healthcare consultation and minor treatment to customers on the Airtel network.

The partnership between the two companies is aimed at increasing access to affordable healthcare services in Nigeria, especially in rural areas where healthcare facilities are limited.

The health bundle, which is accessible by dialing 14144#, offers telemedicine, pharmacy, and hospitalization reimbursement services to Airtel customers.

The telemedicine service allows users to consult with medical professionals via their mobile phones, while the pharmacy service provides medication at discounted rates. The hospitalization reimbursement service covers up to N50,000 per year for hospitalization expenses.

Femi Oshinlaja, the Chief Commercial Officer of Airtel Nigeria, expressed his excitement at the launch of the digital health insurance scheme, stating that it is in line with Airtel’s core value of providing solutions that improve the lives of its customers.

He added that the partnership with AXA Mansard will offer easy and pocket-friendly health insurance access to Airtel users through mobile data service.

Tope Adeniyi, the Managing Director and Chief Executive Officer of AXA Mansard, also spoke about the partnership, saying that the collaboration will make health insurance accessible through mobile services, providing one of the most innovative and relevant solutions that will empower more Nigerians to access best-in-class health insurance value offerings.

The launch of the digital health insurance scheme is a significant step towards achieving universal health coverage in Nigeria, as it offers an affordable and convenient way for Nigerians to access healthcare. This initiative is particularly important in a country where healthcare services are expensive, and many people cannot afford basic medical treatment.

Comments

Trending

Exit mobile version